Para citar este trabalho use um dos padrões abaixo:
Guarana (Paullinia cupana) is an Amazonian crop rich in antioxidant and stimulant bioactive compounds. As it shares phytochemicals with coffee and tea, whose consumption has been associated with a lower risk of Parkinson's disease (PD), its bioactive potential warrants investigation. Herein, we evaluated the metabolomic profile and antioxidant, antimicrobial, and cytoprotective properties of guarana extracts obtained using different extraction methods. Commercial powdered guarana from producers in the Brazilian states of Amazonas (AM) and Mato Grosso (MT) was extracted by room-temperature (RT) sonication or hot aqueous extraction (H), followed by freeze-drying. Extracts were characterized by total phenolic content (TPC), antioxidant capacity (ABTS, DPPH, and FRAP), and 1H-NMR-based metabolomic profiling. Antimicrobial activity against Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli, and Staphylococcus aureus was evaluated by broth microdilution and OD600 measurement. Cytoprotective effects were assessed in rotenone-challenged STC-1 enteroendocrine cells relevant to gut-brain axis research, pretreated with extracts for 4 h before MTT-based cell viability analysis. Functional assays were performed in three independent experiments, and statistical comparisons were performed using Tukey’s multiple comparisons test. 1H-NMR metabolomic profiling was performed in two independent experiments, each in duplicate. RT extracts exhibited the highest antioxidant potential and phenolic content, with RTAM presenting the greatest ABTS activity (840.13±4.45 μmol TE/mL), FRAP value (1943.5±48.1 μmol TE/mL), and TPC (371.13±6.60 mg GAE mL⁻¹), all expressed per mL of reconstituted freeze-dried extract. Antimicrobial activity varied according to extract type, concentration (0.0625-1 mg/mL), and bacterial species. HAM was the only extract to produce dose-dependent growth inhibition against all microorganisms evaluated, significantly inhibiting P. aeruginosa at ≥0.125 mg/mL, P. mirabilis at ≥0.25 mg/mL, and S. aureus at 1.0 mg/mL, whereas RTAM showed no inhibitory activity. Metabolomic profiling identified 18 discriminant metabolites. The PLS-DA model showed high predictive performance (three optimal components; Q2≥0.86) and robust validation by permutation testing (1,000 permutations; p<0.001). Principal component and hierarchical clustering analyses discriminated the extraction methods, while PLS-DA identified (+)-catechin, isoleucine, caffeine, malate, leucine, sucrose, succinate, alanine, glucose, and 4-aminobutyrate as the principal discriminant metabolites, with (+)-catechin showing the highest variable importance in projection score. Despite their distinct metabolomic profiles, all extracts significantly attenuated rotenone-induced cytotoxicity in a concentration-dependent manner. At 0.5 mg/mL, HAM and RTAM restored STC-1 cell viability to levels comparable to the untreated control (93.44±5.00% and 91.65±10.31%, respectively), while all extracts significantly increased viability compared with the rotenone-treated group. Overall, distinct extraction methods generated chemically distinct guarana extracts exhibiting in vitro antioxidant and antimicrobial activities and cytoprotective effects in rotenone-challenged enteroendocrine cells. Funding: FAPESP Grant #2021/15224-8.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo